The reduced tumour burden was accompanied by a four‐fold increase in H‐2Kb‐SIINFEKL+ CD8+ T cell frequencies in the blood of ACM‐OVA + ACM‐CpG immunised mice on day 20 p.i., as compared to the control groups (Figure 3F). Here, CD8A is linked to neoplasm.